Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
1.470
0.00 (0.00%)
Feb 14, 2025, 4:00 PM EST
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $228.52 million as of February 18, 2025. Its market cap has decreased by -73.75% in one year.
Market Cap
228.52M
Enterprise Value
55.82M
Revenue
21.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.47
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from 538.37M to 228.52M, a decrease of -57.55%. That is a compound annual growth rate of -17.56%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 14, 2025 | 228.52M | -29.65% |
Dec 31, 2024 | 324.84M | -51.64% |
Dec 29, 2023 | 671.70M | 22.71% |
Dec 30, 2022 | 547.37M | -23.44% |
Dec 31, 2021 | 714.99M | 17.04% |
Dec 31, 2020 | 610.91M | 13.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo Inc. | 2.16B |
SS Innovations International | 1.72B |
Nika Pharmaceuticals | 1.02B |
Veradigm | 907.21M |
Elite Pharmaceuticals | 566.18M |
Glass House Brands | 482.92M |
Northwest Biotherapeutics | 328.28M |
CytoDyn | 266.89M |